New gel aims to stop chemo side effect that makes hands hurt
Prevention
Not yet recruiting
This study tests a gel called TAR-0520 to see if it can prevent hand-foot syndrome, a painful skin reaction caused by the chemotherapy drug capecitabine. About 25 people with breast or colorectal cancer will apply the gel to their hands twice daily for 12 weeks. Their feet will n…
Phase: PHASE2 • Sponsor: Tarian Pharma • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC